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ABSTRACT During the course of an infection, viruses take advantage of a variety of mechanisms to travel in cells, ranging from
diffusion within the cytosol to active transport along cytoskeletal ﬁlaments. To study viral motility within the intrinsically hetero-
geneous environment of the cell, we have developed a motility assay that allows for the global and unbiased analysis of tens
of thousands of virus trajectories in live cells. Using this assay, we discovered that poliovirus exhibits anomalously rapid intra-
cellular movement that was independent of microtubules, a common track for fast and directed cargo transport. Such rapid
motion, with speeds of up to 5 mm/s, allows the virus particles to quickly explore all regions of the cell with the exception of
the nucleus. The rapid, microtubule-independent movement of poliovirus was observed in multiple human-derived cell lines,
but appeared to be cargo-speciﬁc. Other cargo, including a closely related picornavirus, did not exhibit similar motility. Further-
more, the motility is energy-dependent and requires an intact actin cytoskeleton, suggesting an active transport mechanism. The
speed of this microtubule-independent but actin-dependent movement is nearly an order of magnitude faster than the fastest
speeds reported for actin-dependent transport in animal cells, either by actin polymerization or by myosin motor proteins.INTRODUCTION
The interior of eukaryotic cells is an extremely crowded
environment consisting of a densely packed network of
organelles, macromolecules, and the cytoskeleton. Whereas
small molecules are able to passively diffuse in the cyto-
plasm, larger complexes, vesicles, and organelles with
molecular masses >500 kDa typically require active trans-
port during fundamental cellular processes such as endocy-
tosis, membrane trafficking, and cytokinesis (1). Both actin
filaments and microtubules contribute to intracellular
motility by serving as tracks for cargo transport by motor
proteins, including kinesins and dyneins, which travel along
microtubules, and myosins, which travel along actin fila-
ments (2–4). In addition, actin polymerization itself can
propel cargo resulting in characteristic actin ‘‘comet-tails’’
(5). Each of these active intracellular transport mechanisms
is reported to exhibit a characteristic range of speeds. Actin
polymerization has been shown to propel cargo in mamma-
lian cells with speeds of up to ~0.4 mm/s (6). The processive
human myosins (Va, VI, and X) travel at speeds as high as
0.3–0.9 mm/s in vitro and 0.1–0.4 mm/s in live cells (7–12).
Kinesin- and dynein-based cargo transport typically occurs
at much faster speeds of up to several mm/s (13). Recent
studies on various cargos including viruses have extended
our understanding of transport in the complex environment
of the cell and have revealed the emerging role of the cargo
itself in directing intracellular transport and cytoskeletal
dynamics (14,15).
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0006-3495/09/09/1647/10 $2.00Given the fact that viruses need to enter and exit cells, it
comes as no surprise that viruses have adapted to use the
cell’s many transport systems to efficiently infect their hosts
(16,17). Many viruses have been observed to use active
transport along microtubule and/or actin tracks. For example,
murine leukemia virus, avian leukosis virus, human immu-
nodeficiency virus (HIV), papillomavirus, and vesicular
stomatitis virus use the cortical actin cytoskeleton, together
with myosin II, for directed movement along actin rich filo-
podia (18,19). After entering the cell, many viruses, such as
adenovirus, herpes simplex virus, HIV, and influenza virus
are able to travel along microtubules to reach a specific site
for genome release (20–23). In addition to using motor
proteins to travel along existing cytoskeletal tracks, viruses
are also able to manipulate the actin polymerization
machinery to propel themselves deeper into the cell, as in
the case of simian virus 40 (24), or to exit the cell, as in
the case of vaccinia virus (25). Because viruses widely
exploit diverse cellular mechanisms for motility, they are
natural probes of intracellular transport, prompting investiga-
tion of viral transport both at a fundamental level and as
a potential target for antiviral therapies (17,26–28).
Here, we examine the intracellular transport of poliovirus
(PV), a ~9000 kDamodel pathogen for the study of nonenvel-
oped RNA viruses such as rhinoviruses, enteroviruses, echo-
viruses, and hepatoviruses (29,30). By tracking individual
viral particles in live cells, we discovered anomalously rapid,
microtubule-independent but actin-dependent motility of
internalized PV with speeds as high as 5 mm/s. This type of
motility was observed in multiple types of cell lines but was
cargo specific. Remarkably, the observed speed is nearly an
order of magnitude higher than the fastest speeds reported
for actin-dependent transport mechanisms in animal cells.
doi: 10.1016/j.bpj.2009.07.011
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Cell culture, viruses, reagents, and plasmids
Additional information regarding cell culture, viruses, reagents, and plas-
mids is described in the Supporting Material.
Drugs
All inhibitorswere purchased fromSigmaAldrich (St. Louis,MO) and used at
the following concentrations: nocodazole (60 mM), sodium azide (20 mM),
cytochalasin D (5–20 mM), latrunculin B (25 mM), latrunculin A (10 mM),
jasplakinolide (1 mM), and blebbistatin (200 mM). Drugs were dissolved in
a minimum volume of DMSO to make a concentrated stock solution, and
the concentrated stock solution was then diluted in culture media during
experiments. For all tracking experiments, cells were incubated with the
appropriate concentration of inhibitor at 37C for at least 50 min before
data acquisition unless otherwise indicated. Because some drugs inhibit PV
internalization, for all experiments except those shown in Figs. 1 and 2, PV
was allowed to enter cells first for 10 min followed by a wash step and then
incubation with the drug. Data acquisition in this case was started 60 min
past PV infection, unless otherwise indicated, ensuring the full effect of the
chosen drug. All experiments using sodium azide treatment of cells also
included treatment with 25 mM deoxyglucose that helps to reduce cellular
levels of ATP. The intensity of green 514 nm laser light used during the bleb-
bistatin experiments (every tenth frame) was <1.6  104 W/cm2, which is
much less than the intensity regime reported by Sakamoto et al. to be capable
of photoinactivating blebbistatin (Fig. S13 in the Supporting Material) (31).
Fluorescence microscopy
Two-color live cell fluorescence imaging was carried out using a customized
Yokogawa spinning disk confocal scan head attached to an Olympus IX-71
microscope (Olympus, Center Valley, PA) with an Olympus 60, 1.35 NA
oil-immersion objective. The 514 nm line of an argon ion laser and the 647
nm line of a krypton ion laser were used to excite the lipophilic membrane
dye R18 and cargo (Cy5 labeled PV, Cy5 labeled Seneca Valley Virus, or
Alexa 647 labeled transferrin), respectively. The fluorescence from the
two fluorophores was separated using a 650 nm longpass dichroic beamsplit-
ter (Chroma, Rockingham, VT) and imaged onto two separate regions of
an Andor 885 electron-multiplying charge coupled device camera for simul-
taneous two-color imaging. Because the R18 fluorescence has a weak cross-
talk (that was subtracted, see below) into the 647 nm channel, we typically
exposed only one out of every 10 frames with 514 nm laser light, whereas
the 647 nm laser continuously illuminated the sample. R18 signals were
filtered using a 570/80 nm bandpass emission filter (Chroma). Cy5 or Alexa
647 signals from cargo were filtered using a 665 nm longpass emission filter
(Chroma). Except where otherwise indicated, movies were collected at
a frame rate of 4 Hz for 400–500 frames. In all movies, the confocal micro-
scope focal plane was positioned above the bottom of the cells in a plane that
optically cut though the nucleus as shown in Fig. S2.
All experiments were conducted at 37C using ~75% confluent cells in
Ibidi (Munich, Germany) m-slide VI chambers. Imaging was carried out in
phenol red free Dulbecco’s modified Eagle’s medium containing 50 mM
Hepes and one of two oxygen scavenging systems depending on the experi-
ment. All experiments except for those involving treatment by sodium azide/
deoxyglucose used a glucose oxidase/catalase based oxygen scavenging
system (32) consisting of 1% glucose, 0.5 mg/mL glucose oxidase (Sigma-
Aldrich), and 40 mg/mL catalase (Roche Applied Science, Indianapolis,
IN). The glucose oxidase system provided superior photostability, but was
not suitable for experiments involving sodium azide/deoxyglucose treatment
because glucose counteracts the effectiveness of deoxyglucose. Instead, for
all experiments involving sodium azide/deoxyglucose, we used a glucose-
free oxygen scavenging system based on the enzyme protocatechuate dioxy-
genase (PCD) (33,34). This alternative oxygen scavenging system uses PCD
(Sigma-Aldrich) added to a final activity of 0.5 U/mL, and its substrate
Biophysical Journal 97(6) 1647–1656protocatechuate (Sigma-Aldrich) added to a final concentration of 50 mM.
Control experiments on nocodazole-treated cells (not shown) using the
PCD oxygen scavenging system showed identical motility to that measured
in nocodazole-treated cells when using the glucose oxidase/catalase system.
Particle tracking and data analysis
Image processing and data analysis were carried out using custom written
MATLAB (The MathWorks, Natick, MA) and IDL software (ITT Visual
Information Solutions, Boulder, CO). Initial steps included the application
of a spatial Fourier bandpass filter to remove high and low frequency back-
ground noise, the registration of dual-channel movies to account for optical
aberrations or differences in magnification between the two channels, and
the subtraction of aweak (4%) crosstalk of theR18 signal from theCy5/Alexa
647 channel. Particles were tracked using custom-written software based on
an algorithmdescribedpreviously (35) thatwasmodified to reliably obtain the
trajectories for all particles identified in large batches of movies in an auto-
mated fashion. In some movies, there was a slow lateral drift of the micro-
scope stage, which was corrected by subtracting off the average motion of
many (mostly) nonmoving particles from all trajectories. Cell boundary
mapswere drawnby handbased onR18membrane signals. The cell boundary
maps were used to select out only those trajectories that occurred entirely
within the interior of the cell whereas ambiguous trajectories that traversed
the edge of the cell were discarded. Although rare, trajectories from cells
that moved significantly on the timescale of the movies (~2 min) were dis-
carded, such that it was sufficient for all movies to use the cell map generated
in one frame for all successive frames. A four-frame vectorialmoving average
filter was applied to the obtained trajectories before analyzing the speed of any
trajectory. The minimum trajectory length was eight frames.
RESULTS
Rapid microtubule-independent motility of PV
To observe the movement of PV in cells, we infected cells
with fluorescently labeled PV and tracked individual virus
particles in live cells using a spinning-disk confocal micro-
scope. Fig. 1 A and Movie S1 in the Supporting Material
show representative examples of PV motility in Hela S3
(human cervical cancer) cells. The great majority of particles
entered cells by 20 min postinfection (mpi) and exhibited
high motility inside the cells. Various types of movements
were observed. Although some particles showed compara-
tively little motion and appeared to be confined to a small
area (e.g., the cyan trajectory in Fig. 1, D and G), others
were able to achieve high transport speeds (e.g., the green,
blue, orange, and red trajectories in Fig. 1, D and G).
Some of these rapidly moving particles exhibited highly
directed movements (e.g., the green and orange trajectories
in Fig. 1, D and G). Interestingly, the static or slowly moving
particles were often localized to distinct vesicular structures
nonspecifically stained by the lipophilic dye octadecyl
rhodamine B (R18) after its internalization from the plasma
membrane (Fig. 1, A and B, Fig. S1, and Movie S2), whereas
the rapidly moving virus particles rarely colocalized with
R18. Similar results were observed with other lipid markers,
including DiI and NBDPS (data not shown), suggesting that
the rapidly moving viruses were either sorted to highly
specific endocytic vesicles that were not labeled by general
purpose membrane markers, or were free inside the cytosol.
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FIGURE 1 Motion of PV in untreated and nocodazole or sodium azide-treated cells. Confocal images (A–C) of PV (magenta) in live cells labeled with R18
(green; see alsoMovie S1, Movie S3, andMovie S4). Representative trajectories are overlaid in yellow.Magnified views of these trajectories are shown inD–F,
and their instantaneous speed as a function of time are shown inG–I. Cellswere pretreatedwith drug (60mMnocodazole or 20mMsodiumazide) for 50min before
incubationwithCy5-labeled PV for 10min at a lowmultiplicity of infection (MOI¼ 1 pfu/cell). Just before imaging, cellswere briefly incubatedwithR18,which
nonspecifically stained the plasma membrane and allowed the determination of the boundary of the cell and the observation of R18-stained vesicles. The red
arrowheads in A and B indicate examples where PV colocalizes with R18-labeled vesicles. Successive points in trajectories are separated by 0.25 s.The optical sectioning power of confocal microscopy allows
us to rule out the possibility that these rapidly moving parti-
cles were on the cell surface—only the trajectories from
particles inside the cell significantly far away from the
plasma membrane, as marked by the lipophilic dyes, were
analyzed (Fig. S2). Note that because the movements of
virus particles inside the cell typically occur in all three
dimensions, we only measured a two-dimensional projection
of three-dimensional motion. The speeds calculated from the
two-dimensional projection therefore represent lower
bounds to the actual speeds.
Given the high motility of PV observed inside the cell
during infection, we tested whether all movements were
caused by microtubule-based motor proteins, which are
known to transport cargo at speeds of up to several mm/s
(13). Surprisingly, treatment of cells with nocodazole (that
has been shown previously to have no affect on the effi-
ciency of infection (36)) only moderately reduced the
motility of PV (Fig. 1 B, Movie S3), despite the fact that no-
codazole treatment completely depolymerized microtubules
(Fig. S3). Virus particles were still able to achieve high
speeds of several micrometers per second (up to 5 mm/s),
often for multiple consecutive frames (e.g., orange, blue,and green trajectories, Fig. 1 E and H). The observation
that these high speeds are sustained for several consecutive
frames suggests that they are unlikely due to artifacts arising
from frame-to-frame noise. To further illustrate this point, we
carried out additional measurements at a higher frame rate of
20 Hz (instead of the 4 Hz frame rate used in recording data
in Fig. 1). We then carried out a vectorial moving average of
four consecutive points to generate smoothed virus trajecto-
ries that are used to calculate the speed of movement. Even
after treatment with such a low-pass filter, speeds as high
as 5 mm/s sustained for several frames were observed for
PV in nocodazole-treated cells (Fig. S4).
To test whether the observed rapid, microtubule-indepen-
dent motility of PV resulted from passive diffusion, we
depleted cells of ATP by incubating the cells with sodium
azide such that active processes in the cell were suppressed
(37). We have shown previously that this treatment inhibits
poliovirus infection (36). In contrast to untreated and noco-
dazole-treated cells, PV particles in sodium azide-treated
cells were overwhelmingly static and were mainly found at
the periphery of cells (Fig. 1, C, F, and I, and Movie S4),
suggesting that passive diffusion cannot account for the rapid
intracellular motility of PV. It should be noted that
Biophysical Journal 97(6) 1647–1656
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FIGURE 2 Quantitative analysis of
PV motion. (A–C) Color overlays of all
PV trajectories identified in representa-
tive movies of untreated, nocodazole-
treated (Noco), and sodium azide-treated
(NaAz) cells (see also Movie S1, Movie
S3, and Movie S4). The corresponding
still frames of the movies are shown in
Fig. 1,A–C. Thewhite cell maps indicate
the interior of the cells as identified
by confocal images of the plasma
membrane marker R18, and the dashed
lines represent the outlines of the nuclei.
Trajectories not contained entirelywithin
the white cell maps are rendered in gray
and were excluded from further analysis.
All movies were 400–500 frames (100–
125 s) long. Scale bars in A–C ¼ 5 mm;
~40,000 trajectories from ~150 cells
and 61movieswere used for the analysis.
(D) PV peak speed distributions in
untreated (green), nocodazole-treated
(blue), and NaAz-treated (red) cells.
The speeds shown here and subsequently
are calculated from the viral trajectories
after four-point moving average. (E)
Survival function plot of the observed
peak speed distribution. The survival
function plot shows along the y axis the
fraction of trajectories with peak speed
higher than the corresponding threshold
value given in the x axis. (F) Percentage
of trajectories with peak speeds above 0.5 mm/s. (G) Percentage of trajectories that are categorized as ‘‘fast and directed’’ and ‘‘fast and undirected’’ as defined
in the text. Error bars ¼ SE. (H) Mean-square displacement (MSD) analysis of the fast and directed subgroup and (I) of the fast and undirected subgroup for
untreated (green), nocodazole (blue), and NaAz (red)-treated cells. Shown in the plots is the average MSD of all trajectories within the indicated subgroup.pretreatment of cells with sodium azide also prevented a large
fraction of virus particles from being internalized. Here we
selectively analyzed those trajectories that were inside the
cells, as indicated by their significant separation from the
R18-labeled cell membrane in the confocal image. As
control experiments, we added sodium azide to cells after
PV had been already internalized. These experiments yielded
a substantially larger number of virus trajectories inside the
cell, among which the great majority were also static
(Fig. S5 and Movie S5).
Quantitative analysis of PV motility
The study of viral transport is often complicated by the fact
that the intracellular environment is complex and heteroge-
neous and that viruses can exploit multiple cellular mecha-
nisms simultaneously (28). To characterize and compare
the full spectrum of viral motility, it is therefore necessary
to track a large number of virus particles in cells and quanti-
tatively analyze their behavior such that specific types of
motion can be characterized, the fractions of viruses showing
each type of motion can be determined, and the effects of
various inhibitors on each type of motion can be assessed
with confidence. To this end, we developed a motility assay
that recorded the motion of many virus particles in cells
Biophysical Journal 97(6) 1647–1656using a confocal microscope and analyzed their movements
using an automated particle tracking algorithm. The obtained
viral trajectories were then compared with the cell bound-
aries derived from the fluorescence image of a plasma
membrane marker to ensure that only viruses inside the
cell were analyzed. Cells were infected with PV with an
MOI of 1, a physiologically relevant condition in which there
are ~100–300 viruses per cell and a similar number of
observed trajectories. All of the trajectories observed in the
example movies corresponding to Fig. 1, A–C, (Movie S1,
Movie S3, and Movie S4) are displayed in Fig. 2, A–C, in
different colors on top of a white background indicating
the interior of the cells. The viral trajectories in untreated
and nocodazole-treated cells showed that PV particles not
only moved rapidly but were also able to access nearly all
regions of the interior of the cell except for the nucleus.
We note that although the density of trajectories seems to
be high in Fig. 2, not all trajectories were recorded simulta-
neously. The trajectories that appear to overlap in space did
not overlap in time and thus did not cause ambiguity in
tracking.
Statistical analyses were then carried out on tens of thou-
sands of PV trajectories taken from ~150 cells in many inde-
pendent experiments. One of the parameters we extracted
from each trajectory is the peak speed, defined as the
Rapid Viral Motility 1651maximum speed observed during the trajectory. To faith-
fully track rapidly moving virus particles, we imaged the
sample at a relatively high frame rate (4 Hz). Before calcu-
lating the peak speed of each trajectory, a four-frame vecto-
rial moving average was applied to all trajectories to reduce
noise in the speed analysis and to avoid artifactual high-
speed excursions that typically lasted for only one frame
resulting from frame-to-frame noise. The peak speed distri-
butions were then constructed from ~20,000, ~20,000, and
~3000 viral trajectories in untreated, nocodazole-treated,
and sodium azide-treated cells, respectively (Fig. 2 D). Plot-
ting this data in the form of a survival function allows
comparison of motility over the full range of observed
speeds (Fig. 2 E). In addition to these full speed distribu-
tions, we also present the fraction of trajectories with speeds
above 0.5 mm/s to offer a simpler comparison for the
motility of rapidly moving particles under different condi-
tions (Fig. 2 F). For instance, the percentage of trajectories
with peak speeds >0.5 mm/s is 28% in untreated cells, 19%
in nocodazole-treated cells, and 2.5% in sodium azide-treated
cells. This threshold value of 0.5 mm/s was chosen because it
represents the upper speed limit of previously reported actin-
dependent movements in mammalian cells. We note that the
trend of how the fraction of rapidly moving particles changes
under different drug conditions does not substantially
depend on the choice of the threshold value because the
survival functions appear roughly linear on a semilogarithmic
plot and the curves under different conditions rarely cross
each other (Fig. 2 E). Time course experiments revealed
that the fast, microtubule-independent PV motility inside
the cell was achieved after 15 mpi and lasted until at least
80 mpi without any significant decrease (Fig. S6). This al-
lowed us to probe PV motility at a variety of time points
past infection.
In addition to speed, we also analyzed the shape of trajec-
tories to elucidate what type of cytoskeletal tracks the viruses
might be moving on. According to the speed and trajectory
shape, we categorized trajectories as either: i), ‘‘slow’’—
with a peak speed below 0.5 mm/s; ii), ‘‘fast and
directed’’—having a peak speedR0.5 mm/s and possessing
5 or more consecutive steps with <30 turns between steps;
or iii), ‘‘fast and undirected’’—having a peak speed R0.5
mm/s but not satisfying the directedness criterion given
above. Many approaches, such as mean-square displacement
(MSD) analysis, can be used for the identification of directed
and undirected trajectories (38–40). The simple trajectory
sorting criteria used here facilitates global analysis of an
extremely large number of trajectories (on the order of tens
to hundreds of thousands), which is important for drawing
unbiased and statistically significant conclusions of viral
motility in a heterogeneous environment like the interior of
a cell. Despite involving relatively arbitrary thresholds for
discriminating fast versus slow and directed versus undi-
rected trajectories, these criteria were nonetheless adequate
to allow statistically significant comparisons betweendifferent drug treatment conditions. In addition, these criteria
also allow us to sort out the small fraction with trajectories
with directed movement among a relatively large population
of undirected trajectories, or the short, transient bursts of
directed movements in a long trajectory, both of which
tend to be masked by ensemble or full-trajectory MSD
analysis. According to these simple criteria, 9% of the PV
trajectories in untreated cells were fast and directed, 19%
were fast but undirected, whereas the remaining were slow.
In contrast, only 1% of the trajectories in nocodazole-treated
cells were fast and directed, whereas the fast and undirected
fraction (18%) remained at a similar level to that observed in
untreated cells (Fig. 2 G). These results indicated that the fast
and directed movements obtained in untreated cells were
largely due to microtubule-dependent transport, consistent
with the facts that microtubules have a persistence length
of ~5 mm (41) and that kinesins and dyneins in cells often
exhibit highly processive motion with run lengths of up to
several micrometers (42). Sodium azide-treated cells showed
a nearly undetectable amount of fast and directed trajectories
and a drastic reduction of the fast and undirected trajectories
(to only 2%), suggesting that the fast and undirected move-
ments observed in untreated and nocodazole-treated cells
required energy and were thus unlikely to be the result of
passive diffusion despite its undirected appearance. We
have also calculated the false positive rate of identifying
a fully undirected trajectory as being directed using the
above criteria. This rate (~3%) is much lower than the fast
and directed subpopulation identified in untreated cells but
comparable to the small fraction of fast and directed trajecto-
ries identified in nocodazole-treated cells (Fig. S7), indicating
that the identified directed movements were statistically
significant only in untreated cells but not in nocodazole-
treated cells. By varying the parameters used in the trajectory
sorting criteria, we found these qualitative conclusions to be
insensitive to the parameter choice (Fig. S7).
As expected, MSD analysis of the fast and directed
subgroup shows a clear superlinear dependence on time
(Fig. 2 H), whereas the MSD of the fast and undirected
subgroup shows an approximately linear or slightly sublinear
dependence on time (Fig. 2 I). The MSD analysis lends
further support to our trajectory sorting procedure. Interest-
ingly, the average MSD for the fast and directed subgroup
decreased substantially on nocodazole treatment whereas
the average MSD for the fast and undirected subgroup are
nearly identical for untreated and nocodazole-treated cells,
suggesting that the apparently fast and undirected move-
ments observed in untreated and microtubule-disrupted cells
share a similar mechanism. As anticipated earlier, the
ensemble average MSD of all trajectories show a linear
dependence on time (Fig. S8), masking the small fraction
of trajectories with directed movement. Trajectories with
directed movements transiently appearing as short bursts
often exhibit a linear MSD versus time behavior too (data
not shown).Biophysical Journal 97(6) 1647–1656
1652Comparison of PV motion to other cargos
and in different cell types
The above results show that PV is likely transported actively
with speeds up to several micrometers per second in cells
lacking intact microtubules. This is surprising considering
that such high speeds are typically associated with transport
by motor proteins on microtubules. To verify the absence of
microtubules in nocodazole-treated cells we not only stained
for tubulin as shown in Fig. S3 but also carried out experi-
ments in green fluorescent protein (GFP)-tubulin expressing
and nocodazole-treated cells (data not shown) and in neither
case were microtubular structures observed. Next, we tested
whether this type of motility was specific to the cargo or cell
type used. In addition to the HeLa S3 cell lines used above,
we studied PV motility in two additional cell lines, H446
(human lung carcinoma) and Hep 3B (human hepatocellular
carcinoma). In these two cell lines, 36% and 26% of PV
trajectories showed a peak speed of R0.5 mm/s, respec-
tively, which is comparable to the 28% observed in HeLa
S3 cells (Fig. 3 and Fig. S9). On treatment with nocodazole
to disrupt microtubules, the fraction was only moderately
reduced (by 1.7 and 1.8-fold), also comparable to the 1.4-
fold reduction observed in HeLa S3 cells (Fig. 3 and
Fig. S9).
To test the cargo specificity, we chose two other cargoes
for comparison: transferrin, a well characterized ligand
responsible for iron delivery to the cell (14,43), and Seneca
Valley Virus, a virus that belongs to the same family as PV
(Picornaviridae) and is identical in size to PV (44,45). In
contrast to PV, the fraction of fast transferrin trajectories
was drastically reduced (by 5.2-fold) on depolymerization
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FIGURE 3 Comparison of motility between different cell types and
different cargos. To examine the motility of various cargos in microtu-
bule-disrupted cells, cells were first incubated with cargo (PV, transferrin
(TFN), or Seneca Valley Virus (SVV)) for 10 min to allow internalization
and were then treated with 60 mM nocodazole for 50 min to disrupt micro-
tubules. More than 190,000 trajectories were analyzed. Error bars¼ SE. The
comparison between PV and SVV were not carried out in HeLa S3 cells, but
in H446 cells as the HeLa S3 cells cannot be infected by SVV. Survival
function plots of the full speed distributions for the data shown here may
be found in Fig. S9.
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ison between Seneca Valley Virus and PV was even more
dramatic. In H446 cells, which can be infected by both PV
and Seneca Valley Virus, the viruses are highly dynamic
with 36% of PV trajectories and 27% of Seneca Valley Virus
trajectories exhibiting a peak speed R0.5 mm/s. However,
the treatment of cells with nocodazole caused the fraction
of fast Seneca Valley Virus trajectories to plummet to 2%,
whereas 20% of PV trajectories remained fast (Fig. 3,
Fig. S9, and Movie S6). Despite being members of the
same family and equal in size, the two viruses apparently
use different means for cellular transport. The rapid, micro-
tubule-independent transport is therefore cargo-specific but
not cell type-dependent.
The fact that the motility of transferrin and Seneca Valley
Virus was strongly inhibited by nocodazole treatment further
supports the notion that our nocodazole treatment success-
fully depolymerized microtubules and that the rapid motion
of PV in nocodazole-treated cells is not attributable to micro-
tubule-based motor proteins. Additionally, because PV and
Seneca Valley Virus are of the same size and would be
expected to diffuse with similar speeds, the fact that Seneca
Valley Virus particles appeared largely static in nocodazole-
treated cells lends further credence to the idea that the rapid
microtubule-independent motility of PV did not result from
diffusion, but was due to active transport.
Actin dependence of PV motility
Given that the rapid motility of PV is most likely active,
independent of microtubules, and present in multiple
human-derived cell lines, we next sought to explore the
mechanism of this motility by testing whether it depends
on the actin cytoskeleton. To this end, cells were treated
with the pharmacological drugs cytochalasin D, latrunculins
A and B, and jasplakinolide, which perturb the actin cyto-
skeleton in different ways. To focus only on the microtu-
bule-independent movement, we treated the cells studied
here also with nocodazole to eliminate microtubule-depen-
dent transport. Because the uptake of PV itself requires an
intact actin cytoskeleton (36), we first incubated the cells
with PV for 10 min to allow virus entry before drug treat-
ment. Interestingly, the microtubule-independent motility
of PV was strongly reduced by cytochalasin D treatment
(Fig. 4 A and Fig. S11). This significant reduction is depen-
dent on the concentration of cytochalasin D as shown in
Fig. S12. Treatment with latrunculins A and B or jasplakino-
lide yielded a more moderate reduction in PVmotility. Given
that cytochalasin D binds to the barbed, fast growing end of
actin and depolymerizes actin filaments, the above results
suggest that the rapid motility of PV requires an intact actin
cytoskeleton but depends, to a lesser extent, on the dynamic
behavior of actin, which is inhibited either by sequestering
actin monomers, as in the case of latrunculins A and B, or
by stabilizing actin filaments, as in the case of jasplakinolide.
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H446 cells (Fig. 4 C).
Given that the formin-induced polymerization of actin fila-
ments can achieve speeds of up to 3 mm/s and that the propul-
sion of cargo by actin comet tails was observed at speeds of up
to 0.4 mm/s, respectively (6,46), we tested for the possibility
that actin polymerization is responsible for the observed PV
motility using two approaches. First, we assayed the motility
of PV at various time points after incubationwith cytochalasin
D (Fig. 4 B), which is known to almost immediately inhibit
actin polymerization but only completely disrupt the actin
cytoskeleton after relatively long treatment. In both cases of
polymerization of actin filaments and cargo propulsion by
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FIGURE 4 Actin dependence of PV motility. (A) Effects of the actin per-
turbing drugs cytochalasin D (CCD, see also Movie S7), latrunculin A
(LatA), latrunculin B (LatB), and jasplakinolide (Jas), and the myosin II
inhibitor blebbistatin (Bleb) on the observed motility of PV in HeLa S3 cells.
Survival function plots of the full speed distributions for the data shown here
may be found in Fig. S11. (B) Inhibition of PV motility in H446 cells by
treatment of CCD. (C) CCD inhibition of PV motility over time. HeLa S3
cells were pretreated for 50 min with nocodazole, infected with PV for
10 min, and then incubated with CCD. Movies were recorded at different
time points (10–60 min) after CCD addition, indicating that significant
inhibition of PV motility did not occur until at least 20 min after CCD incu-
bation. Error bars ¼ SE.actin comet tails, cytochalasin D fully inhibited motility
within 2 min of drug treatment (46,47). Here, we do not
observe such a quick effect—significant inhibition of PV
motility by cytochalasin D was only observed after at least
20 min of treatment (Fig. 4 B). Second, we infected cells
stably expressing YFP-actin to search for comet-tail like actin
structures colocalizing with moving PV but saw none. Thus,
known mechanisms of actin polymerization do not seem to
explain the observed motility of PV. Additionally, treatment
of cells with the nonmuscle myosin II inhibitor blebbistatin
(48,49) also caused little inhibition of the microtubule-inde-
pendent PV motion (Fig. 4 A), suggesting that myosin II is
not required for the motility. Although blebbistatin can be
inactivated by irradiation with blue and ultraviolet light
(%488 nm), this effect is unlikely to be present here because
the weak 514 nm light that we used to excite the plasma
membrane marker R18 has an average power density that is
five orders of magnitude lower than the reported photoinacti-
vation regime (31). Indeed, exploiting a commonly used actin
stress fiber assay to test the activity of blebbistatin, we found
the drug to be active under our experimental conditions
(Fig. S13) (50).
Last, we tested whether the rapid, actin-dependent motility
of PV may be associated with myosin motors, we coimaged
PV with a small panel of myosin proteins. To this end, GFP
tagged myosins IIc, Va, Vb, VI, or X (9,51–54) were ex-
pressed in HeLa cells, which were subsequently infected
with fluorescently labeled PV. The results are largely nega-
tive. None of these five myosins tested showed statistically
significant colocalization with rapidly moving PV particles.
A fraction of slow or nonmoving PV particles showed
substantial colocalization with the GFP-labeled myosin VI
or Vb punctae (Fig. S14, A and B, and Movie S8). Some
PV particles were also observed to travel along actomyosin
rich filopodia outlined by GFP-labeled myosin Va and X
(Fig. S13, C and D, and Movie S9). Note that a lack of signif-
icant colocalization between the GFP tagged myosins and
moving PV particles does not rule out the possibility that
a myosin may be involved in the rapid motility of PV,
considering that only a small subset of the 40 known human
myosins were tested here and that the myosin signal colocal-
ized with PV may be too weak to detect if only a small
number of GFP-labeled myosin molecules were associated
with the particle.
DISCUSSION
Various mechanisms, both active and passive, give rise to the
different modes of intracellular transport essential to the
proper function of living cells. Viruses are able to exploit
these mechanisms to infect cells. The study of viral motility
can thus reveal valuable insights not only into virus-cell
interactions but also into endogenous intracellular transport
mechanisms. Here, we report the surprising finding that
PV is capable of rapidly exploring the interior of cells withBiophysical Journal 97(6) 1647–1656
1654 Vaughan et al.unusually high speeds, independent of microtubules. This
was observed by imaging and tracking individual PV parti-
cles in live cells using spinning-disk confocal microscopy.
Considering the wide spectrum of motility observed for virus
particles, due to the presence of multiple transport mecha-
nisms and a heterogeneous intracellular environment, we
developed a quantitative motility assay to track tens of thou-
sands of cargo particles in an automated and unbiased
manner to allow for the systematic characterization of cargo
motility.
Using this assay, we observed that a significant fraction of
PV trajectories exhibits rapid motility in cells lacking intact
microtubules, with ~20% of trajectories showing sustained
speeds above 0.5 mm/s and many particles achieving speeds
of up to 5 mm/s. This motility is both ATP- and actin-depen-
dent, suggesting an active transport mechanism. The peak
speed of the actin-dependent movement observed here in
various human cell lines is an order of magnitude faster
than the highest speed of myosin motors observed in
mammalian cells, although myosin-based transport of
several micrometers per second has been reported for myosin
V in yeast and for myosin XI isolated from plants (55,56).
Cargo transport by actin polymerization also occurs at
a much slower speed (6,25). The anomalously high microtu-
bule-independent but actin-dependent PV motility observed
here also seems to be cargo-specific: microtubule depoly-
merization induces near complete inhibition of motion for
Seneca Valley Virus, a virus that is of the same physical
size and belongs to the same family as PV. The same inhibi-
tion was also found for transferrin as shown here and many
other cargoes as reported in the literature, including vaccinia
virus (57), adenovirus (39), peroxisomes (58), lipid droplets
(59), and endosomes (60).
Although it is presently unclear what exact mechanism
underlies this rapid transport of PV, we propose a few
possible scenarios consistent with our observations. Treat-
ments with cytochalasin D at long times showed a substantial
inhibition of PV motility, whereas those at short times
showed little inhibition. This evidence established that the
motility requires an intact actin cytoskeleton, but that known
forms of actin polymerization for cargo transport, which are
highly sensitive to short cytochalasin D incubations, are
unlikely to be responsible. Furthermore, the nonmuscle
myosin II inhibitor blebbistatin did not inhibit the rapid
motility of PV, suggesting that cortical actomyosin dynamics
are also unlikely to be responsible, owing to the prominent
role of nonmuscle myosin II in actomyosin based motility.
One possible scenario that may account for the observed
motility is the upregulation of the activity/speed of a myosin
motor protein by PV either directly, or indirectly through the
PV receptor or other proteins residing on the PV-harboring
vesicles. The putative myosin may transport PV along
a zigzagged path with frequent turns on the highly cross-
linked actin network, explaining the observation that the
trajectories do not appear directed (61). Though we testedBiophysical Journal 97(6) 1647–1656a few myosin proteins and did not find measurable colocal-
ization between these myosins and the rapidly moving PV,
these results do not exclude the possibility that a myosin
may be involved in the rapid motility of PV. Alternatively,
PV may influence cytoskeletal dynamics (15) to achieve
such high speeds. Drastic actin remodeling induced by PV
has been observed during early and late stages of infection
(62,63). It has also been shown recently that Vaccinia virus
induces rapid and massive rearrangement of the cortical actin
cytoskeleton shortly after binding to the cell (64). A fast
induction of cytoskeleton remodeling after virus binding
and internalization potentially provides an alternative mech-
anism for the rapid motility of PV. Future work will seek to
further clarify the molecular mechanism of the rapid PV
motility by isolating PV (free or vesicle bound) shortly after
internalization and identifying the proteins associated with
the virus or virus harboring vesicles.
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